Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction

Fig. 2

Correlation of TASL expression with immune infiltration signatures. A Relationship between TASL expression and KEGG pathways in 20 cancer types obtained by GSEA. B Spearman’s correlation of TASL expression with CYT, CCR, HLA, TIL and IFN signatures. The ratios of CD8+ T cells to Tregs (C), Th1 cells to Th2 cells (D), and M1 macrophages to M2 macrophages (E) in the TASL low and high expression groups from 20 types of cancers of TCGA (*P < 0.05; **P < 0.01; ***P < 0.001)

Back to article page